Silvio Buchner

Prof. Silvio Buchner

Physics Institute, Federal University of Rio Grande do Sul (IF/UFRGS), Porto Alegre 90040-060, Brazil
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Journal of Luminescence
Verified
Journal Article
Closed access
AHA. Herrera
A. Herrera
RFR.G. Fernandes
R.G. Fernandes
ACAndrea De Camargo
Andrea De Camargo
AHA.C. Hernandes
A.C. Hernandes
Silvio BuchnerSilvio Buchner
Silvio Buchner
NBNaira maria Balzaretti
Naira maria Balzaretti

1 February 2022 in Applied Surface Science
Verified
Journal Article
Closed access
WFWallace T. Figueiredo
Wallace T. Figueiredo
RPRavi Prakash
Ravi Prakash
CVClóvis Guerim Vieira
Clóvis Guerim Vieira
DLDirléia S. Lima
Dirléia S. Lima
VCVágner E. Carvalho
Vágner E. Carvalho
FBFabiano Bernardi
Fabiano Bernardi

1 March 2014 in Journal of Non-Crystalline Solids
Verified
Journal Article
Closed access
Silvio BuchnerSilvio Buchner
Silvio Buchner
APAltair Soria Pereira
Altair Soria Pereira
JLJoão Cardoso de Lima
João Cardoso de Lima
NBNaira maria Balzaretti
Naira maria Balzaretti

26 February 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MVMaiara Callegaro Velho
Maiara Callegaro Velho
NFNadine Lysyk Funk
Nadine Lysyk Funk
MDMonique Deon
Monique Deon
EBEdilson Valmir Benvenutti
Edilson Valmir Benvenutti
Silvio BuchnerSilvio Buchner
Silvio Buchner
Ruy Carlos Ruver BeckRuy Carlos Ruver Beck
Ruy Carlos Ruver Beck
Ivermectin (IVM), a widely used drug for parasitic infections, faces formulation and application challenges due to its poor water solubility and limited bioavailability. Pondering the impact of IVM’s high partition coefficient value (log P) on its drug release performance, it is relevant to explore whether IVM nanoencapsulation in organic or inorganic nanoparticles would afford comparable enhanced aqueous solubility. To date, the use of inorganic nanoparticles remains an unexplored approach for delivering IVM. Therefore, here we loaded IVM in mesoporous silica particles (IVM-MCM), as inorganic nanomaterial, and in well-known poly(ε-caprolactone) nanocapsules (IVM-NC). IVM-MCM had a well-organized hexagonal mesoporous structure, reduced surface area, and high drug loading of 10% w/w. IVM-NC had a nanometric mean size (196 nm), high encapsulation efficiency (100%), physicochemical stability as an aqueous dispersion, and drug loading of 0.1% w/w. Despite differing characteristics, both nanoencapsulated forms enhance IVM’s aqueous intrinsic solubility compared to a crystalline IVM: after 72 h, IVM-MCM and IVM-NC achieve 72% and 78% releases through a dialysis bag, whereas crystalline IVM dispersion achieves only 40% drug diffusion. These results show distinct controlled release profiles, where IVM-NC provides a deeper sustained controlled release over the whole experiment compared to the inorganic nanomaterial (IVM-MCM). Discussing differences, including drug loading and release kinetics, is crucial for optimizing IVM’s therapeutic performance. The study design, combined with administration route plans and safety considerations for humans and animals, may expedite the rational optimization of IVM nanoformulations for swift clinical translation.

1 October 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
CRCristiano Rodrigues
Cristiano Rodrigues
LNLiliana Ivet Sous Naasani
Liliana Ivet Sous Naasani
CZCarla Zanatelli
Carla Zanatelli
TPThaís Casagrande Paim
Thaís Casagrande Paim
JAJéssica Gonçalves Azevedo
Jéssica Gonçalves Azevedo
MWMarcia Wink
Marcia Wink

1 February 2016 in Optical Materials
Verified
Journal Article
Closed access
AHA. Herrera
A. Herrera
Silvio BuchnerSilvio Buchner
Silvio Buchner
RCR.V. Camerini
R.V. Camerini
CJC. Jacinto
C. Jacinto
NBNaira maria Balzaretti
Naira maria Balzaretti